Varian to Host Investor Meeting at ASTRO in Chicago

PALO ALTO, Calif., Aug. 8, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced that its executive staff will be meeting with analysts and investors at the American Society for Radiation Oncology (ASTRO) Annual Meeting in Chicago on Monday, September 16, 2019 at 2:00 p.m. Central Time.

Information about the webcast of the company's presentation will be available through a link on the company website at www.varian.com/investors.

To attend Varian's ASTRO investor meeting, please RSVP to Katie Glenn at katie.glenn@varian.com by August 23, 2019.

For automatic e-mail alerts regarding Varian news and events, investors can subscribe on the company website: http://investors.varian.com/emailalerts.

About Varian

At Varian, we envision a world without fear of cancer. For more than 70 years, we have developed, built and delivered innovative cancer care technologies and solutions for our clinical partners around the globe to help them treat millions of patients each year. With an Intelligent Cancer Care approach, we are harnessing advanced technologies like artificial intelligence, machine learning and data analytics to enhance cancer treatment and expand access to care. Our 9,200 employees across 70 countries keep the patient and our clinical partners at the center of our thinking as we power new victories in cancer care. Because, for cancer patients everywhere, their fight is our fight. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.

                        Forward-Looking Statements

             Except for historical information, this
              news release contains forward-looking
              statements within the meaning of the
              Private Securities Litigation Reform
              Act of 1995. Statements concerning the
              expected impact of proposed tariffs or
              other financial results; and any
              statements using the terms "could,"
              "believe," "expect," "promising,"
              "outlook," "should," "well-
              positioned," "will" or similar
              statements are forward-looking
              statements that involve risks and
              uncertainties that could cause the
              company's actual results to differ
              materially from those anticipated. Such
              risks and uncertainties include the
              final terms of any new tariffs and
              whether any reciprocal tariffs are
              imposed, our ability to achieve
              expected synergies from acquisitions;
              risks associated with integrating
              recent acquisitions; global economic
              conditions and changes to trends for
              cancer treatment regionally; currency
              exchange rates and tax rates; the
              impact of the Tax Cuts and Jobs Act;
              the impact of  the Affordable Health
              Care for America Act (including excise
              taxes on medical devices) and any
              further healthcare reforms (including
              changes to Medicare and Medicaid), and/
              or changes in third-party
              reimbursement levels; recent and
              potential future tariffs or a global
              trade war; demand for and delays in
              delivery of the company's products; the
              company's ability to develop,
              commercialize and deploy new products;
              the company's ability to meet Food and
              Drug Administration (FDA) and other
              regulatory requirements, regulations or
              procedures; changes in regulatory
              environments; risks associated with the
              company providing financing for the
              construction and start-up operations
              of particle therapy centers, challenges
              associated with commercializing the
              company's proton solutions business;
              challenges to public tender awards and
              the loss of such awards or other
              orders; the effect of adverse
              publicity; the company's reliance on
              sole or limited-source suppliers; the
              company's ability to maintain or
              increase margins; the impact of
              competitive products and pricing; the
              potential loss of key distributors or
              key personnel; challenges related to
              entering into new business lines; and
              the other risks listed from time to
              time in the company's filings with the
              Securities and Exchange Commission,
              which by this reference are
              incorporated herein. The company
              assumes no obligation to update or
              revise the forward-looking statements
              in this release because of new
              information, future events, or
              otherwise.

    ---

Press Contact
Mark Plungy
Director, Public Relations
+1 (650) 424-5630
mark.plungy@varian.com

Investor Relations Contact
J. Michael Bruff
Senior Vice President, Investor Relations
+1 (650) 424-5163
investors@varian.com

View original content:http://www.prnewswire.com/news-releases/varian-to-host-investor-meeting-at-astro-in-chicago-300898461.html

SOURCE Varian